Insider Transactions in Q1 2023 at Verona Pharma PLC (VRNA)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 02
2023
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
28,752
-0.93%
|
$57,504
$2.53 P/Share
|
|
Feb 01
2023
|
Claire Poll General Counsel |
SELL
Open market or private sale
|
Indirect |
152,000
-16.41%
|
$304,000
$2.59 P/Share
|
|
Feb 01
2023
|
Claire Poll General Counsel |
BUY
Bona fide gift
|
Indirect |
152,000
+14.1%
|
-
|
|
Feb 01
2023
|
Claire Poll General Counsel |
SELL
Bona fide gift
|
Direct |
152,000
-6.87%
|
-
|
|
Feb 01
2023
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
89,960
-2.81%
|
$179,920
$2.56 P/Share
|
|
Feb 01
2023
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
432,928
-2.44%
|
$865,856
$2.56 P/Share
|
|
Feb 01
2023
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
413,168
-2.45%
|
$826,336
$2.56 P/Share
|
|
Jan 20
2023
|
Claire Poll General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
178,800
+7.48%
|
-
|
|
Jan 20
2023
|
Kathleen A. Rickard Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
105,000
+3.18%
|
-
|